The size of the Large Volume Wearable Injectors Market in Europe is anticipated to showcase a healthy CAGR from 2020 to 2025.
Large volume wearable injectors, a propelled rendition of the current self-infusion gadgets, are expected to receive enthusiasm from a wide client base. Truth be told, there are various such injectors financially accessible for the conveyance of insulin. OmniPod, from Insulet Corporation, is an exceptionally efficient gadget that has produced critical year-on-year income development.
Notwithstanding, it merits featuring that, till date just a single vast volume wearable injector (SmartDose Electronic Wearable Injector) has been endorsed for the organization of a non-insulin biologic. Many organizations are contributing their cash and assets to build up these novel gadgets. Notwithstanding the publicly known projects, pharma organizations have numerous undisclosed projects that are possibly going to give the fundamental development powerful force in the long haul.
This research report on the European Large Volume Wearable Injectors Market has been segmented and sub-segmented into the following categories:
By Application:
By Wearable Injector Type:
By Therapeutic Area:
By Mechanism of Injection:
By Usage:
By Country:
Geographically, factors that are fuelling the growth of the European market are enhanced product efficacy in long term dosage, and predominantly the rising number of patients with chronic long-term disorders. Heavy reimbursements offered by the local authorities in this region paves way for large investments in Research and Developments.
Promising companies leading the European large volume wearable injectors market profiled in this report are Ypsomed AG, West Pharmaceutical Services Inc., Sensile Medical AG, Becton Dickinson and Company, Amgen Inc., Enable Injections Inc., Unilife Corporation and Insulet Corporation.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Application
5.1.1 Introduction
5.1.2 Hospitals
5.1.3 Ambulatory Surgery Centres
5.1.4 Home Care Settings
5.1.5 Clinics
5.1.6 Other Applications
5.1.7 Y-o-Y Growth Analysis, By Application
5.1.8 Market Attractiveness Analysis, By Application
5.1.9 Market Share Analysis, By Application
5.2 Therapeutic Area
5.2.1 Introduction
5.2.2 Infectious Diseases
5.2.3 Diabetes
5.2.4 Oncology
5.2.5 Cardiovascular
5.2.6 Auto-Immune Disorders
5.2.7 Other Therapeutic Areas
5.2.8 Y-o-Y Growth Analysis, By Therapeutic Area
5.2.9 Market Attractiveness Analysis, By Therapeutic Area
5.2.10 Market Share Analysis, By Therapeutic Area
5.3 Mechanism of injection
5.3.1 Introduction
5.3.2 Collapsible Reservoir Rotary Pump
5.3.3 Spring-Based Expanding Battery
5.3.4 Motor-Driven
5.3.5 Pressurized Gas
5.3.6 Y-o-Y Growth Analysis, By Application
5.3.7 Market Attractiveness Analysis, By Application
5.3.8 Market Share Analysis, By Application
5.4 Wearable injector type
5.4.1 Introduction
5.4.2 Hand-Held
5.4.3 Off-body (belt clip)
5.4.4 On-body (adhesive patch)
5.4.5 Y-o-Y Growth Analysis, By Wearable Injector Type
5.4.6 Market Attractiveness Analysis, By Wearable Injector Type
5.4.7 Market Share Analysis, By Wearable Injector Type
5.5 Usage
5.5.1 Introduction
5.5.2 Semi-Reusable
5.5.3 Disposable
5.5.4 Y-o-Y Growth Analysis, By Usage
5.5.5 Market Attractiveness Analysis, By Usage
5.5.6 Market Share Analysis, By Usage
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Application
6.1.3.3 By Therapeutic Area
6.1.3.4 By Mechanism of Injection
6.1.3.5 By Wearable Injector Type
6.1.3.6 By Usage
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Application
6.1.4.3 By Therapeutic Area
6.1.4.4 By Mechanism of Injection
6.1.4.5 By Wearable Injector Type
6.1.4.6 By Usage
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Application
6.1.5.3 By Therapeutic Area
6.1.5.4 By Mechanism of Injection
6.1.5.5 By Wearable Injector Type
6.1.5.6 By Usage
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Dickinson and Company
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Ypsomed AG
8.3 West Pharmaceutical Services Inc.
8.4 Sensile Medical AG
8.5 Becton
8.6 Amgen Inc.
8.7 Enable Injections Inc.
8.8 Unilife Corporation
8.9 Insulet Corporation
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
Download Sample
